Home / Pharma Healthcare / Global Oral Proteins and Peptides Market Research Report 2018

Global Oral Proteins and Peptides Market Research Report 2018

  • Id : RNR-1899
  • Category : Pharma Healthcare
  • Publish Date : 2018
  • Pages : 154
  • Format : PDF
License Type

Description
This report studies the global market size of Oral Proteins and Peptides in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Oral Proteins and Peptides in these regions.
This research report categorizes the global Oral Proteins and Peptides market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

Proteins and Peptides are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases, which can be administered orally are known as oral peptide and protein-based drugs.

The oral protein and peptide-based therapeutics market for diabetes is expected to grow considerably in the near future, owing to factors such as increase in incidence rate of diabetes caused by rapid urbanization and sedentary lifestyle.

The U.S. is anticipated to generate the highest revenue in the oral proteins and peptides market in 2023. The rest of the world possesses high market potential for the growth of the market, owing to increase in awareness about oral peptide and protein therapeutics based treatment and rise in oral peptide and protein therapeutics applications. This region is anticipated to experience fast-paced growth, in terms of development and use of protein therapeutics.

The diabetes application is anticipated to occupy the largest share in the oral proteins and peptides market in 2023 owing to the high adoption of oral insulin, surge in geriatric population, and rise in prevalence of diabetes.

In 2017, the global Oral Proteins and Peptides market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to define, segment, and project the size of the Oral Proteins and Peptides market based on company, product type, application and key regions.

The various contributors involved in the value chain of Oral Proteins and Peptides include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Oral Proteins and Peptides include

    Allergan

    AstraZeneca

    Biocon

    Generex Biotechnology

    Novo Nordisk

    Synergy Pharmaceuticals

    Tarsa Therapeutics

    Sanofi

    Hoffmann-La Roche

    Synthetic Biologics

    Hovione

    Novartis

Market Size Split by Type

    Linaclotide

    Plecanatide

    Calcitonin

    Insulin

    Octreotide

Market Size Split by Application

    Gastric & Digestive Disorders

    Bone Diseases

    Diabetes

    Hormonal Disorders

Market size split by Region

    North America

        United States

        Canada

        Mexico

    Asia-Pacific

        China

        India

        Japan

        South Korea

        Australia

        Indonesia

        Singapore

        Malaysia

        Philippines

        Thailand

        Vietnam

    Europe

        Germany

        France

        UK

        Italy

        Spain

        Russia

    Central & South America

        Brazil

        Rest of Central & South America

    Middle East & Africa

        GCC Countries

        Turkey

        Egypt

        South Africa

The study objectives of this report are:

    To study and analyze the global Oral Proteins and Peptides market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.

    To understand the structure of Oral Proteins and Peptides market by identifying its various subsegments.

    To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

    Focuses on the key global Oral Proteins and Peptides manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

    To analyze the Oral Proteins and Peptides with respect to individual growth trends, future prospects, and their contribution to the total market.

    To project the value and volume of Oral Proteins and Peptides submarkets, with respect to key regions (along with their respective key countries).

    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

    To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Oral Proteins and Peptides are as follows:

    History Year: 2013-2017

    Base Year: 2017

    Estimated Year: 2018

    Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Oral Proteins and Peptides market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.